Log In Sign up
The largest database of trusted experimental protocols
> Devices > Medical Device > Sphygmomanometers

Sphygmomanometers

Sphygmomanometers are medical devices used to measure blood pressure.
They typically consist of an inflatable cuff that is wrapped around the arm and a pressure-measuring instrument.
These devices play a crucial role in the diagnosis and management of hypertension, a major risk factor for cardiovascular disease.
Sphygmomanometer research focuses on improving the accuracy, reproducibility, and reliability of blood pressure measurements, which is essential for patient care and clinical decision-making.
Researchers may use PubCompare.ai to optimize their sphygmomanometer research protocols, access the latest literature, and gain data-driven insights to enhance their studies.
With its AI-powered comparisons and user-friendly platform, PubCompare.ai helps streamline the research process and deliver reliable results for sphygmomanoeter-related investigations.

Most cited protocols related to «Sphygmomanometers»

1
Longitudinal Health Examination Cohort
Data were extracted from a computerised database established by the Rich Healthcare Group in China, which includes all medical records for participants who received a health check from 2010 to 2016. The present analysis initially included all study participants who were at least 20 years old with at least two visits between 2010 and 2016 (n=685 277). Participants were excluded at baseline if they had no available weight and height measurements (n=103 946), no available information on gender (n=1), extreme BMI values (<15 kg/m2 or >55 kg/m2) (n=152) or no available fasting plasma glucose value (n=31 370). We further excluded participants with visit intervals less than 2 years (n=324 233), participants diagnosed with diabetes at baseline (2997 participants diagnosed by self-report and 4115 diagnosed by a fasting plasma glucose ≥7.0 mmol/L), and participants with undefined diabetes status at follow-up (n=6630). Finally, a total of 211 833 participants (116 123 male and 95 710 female) were included in the analysis. Cohort entry was defined as the date of the initial visit. Compared with individuals excluded from the present analyses, those included in the analyses were with similar age (42.1 vs 41.9 years old) and similar BMI (23.2 vs 23.3 kg/m2), and with a relatively higher proportion of males (54.8% vs 52.1%).
In each visit to the health check centre, participants were requested to complete a detailed questionnaire assessing demographic, lifestyle, medical history and family history of chronic disease. Height, weight and blood pressure were measured by trained staff. Body weight was measured in light clothing with no shoes to the nearest 0.1 kg. Height was measured to the nearest 0.1 cm. BMI was derived from weight in kilograms divided by height in metres squared. Blood pressure was measured by standard mercury sphygmomanometers.
Fasting venous blood samples were collected after at least a 10 hours fast at each visit. Serum triglyceride (TG), total cholesterol, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol were measured on an autoanalyzer (Beckman 5800). Plasma glucose levels were measured by the glucose oxidase method on an autoanalyzer (Beckman 5800).
Chen Y., Zhang X.P., Yuan J., Cai B., Wang X.L., Wu X.L., Zhang Y.H., Zhang X.Y., Yin T., Zhu X.H., Gu Y.J., Cui S.W., Lu Z.Q, & Li X.Y. (2018). Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study. BMJ Open, 8(9), e021768.
Publication 2018
Blood Pressure Cholesterol Cholesterol, beta-Lipoprotein Diabetes Mellitus Disease, Chronic Gender Glucose High Density Lipoprotein Cholesterol Light Males Mercury Oxidase, Glucose Plasma Serum Sphygmomanometers Triglycerides Veins Woman
2
Multicollinearity in Epidemiologic Regression
To demonstrate the effect of multicollinearity between predictors in regression models in real life epidemiologic studies, in this section we present the analyses of empirical data from Cameron County Hispanic Cohort (CCHC) using linear regression models. The study population is the Brownsville population represented by CCHC initiated in Cameron County, Texas in 2004, and currently includes more than 3000 participants of age 18 years or older. Information regarding sampling and eligibility criteria of the cohort participants and data collection has been reported previously [29 (link)].
The response variables of interest were baseline systolic blood pressure and diastolic blood pressure as continuous variables. Readings of blood pressure were taken following standard protocols. Participants sat quietly for 5 minutes and then readings were taken three times 5 minutes apart using a Hawksley Random Zero sphygmomanometer. Diastolic blood pressure was determined at the 5th Korotkoff sound. The final pressure was based on the average of the 2nd and 3rd measurements.
The predictors of interest were Body mass index (BMI) and waist circumference (WC), known to be highly correlated obesity related risk factors. Other covariates, such as age at initial visit (baseline), family history of hypertension, smoking and drinking status, as well as education were included in the regression analysis. Waist circumference (visceral adiposity) was measured at the level of the umbilicus to the nearest 10th cm, with the participant in a standing position and breathing normally. Height was measured to the nearest 10th cm using a stadiometer. Weight (to the nearest 10th kilogram) was measured on a calibrated beam balance. BMI was calculated as weight in kilograms divided by height squared in meters (kg/m2).
The Committee for the Protection of Human Subjects at the University of Texas Health Science Center at Houston approved the study protocol, written consent forms and procedures and free and informed consent was obtained from all subjects. The investigators had no conflict of interest to disclose at consent.
Vatcheva K.P., Lee M., McCormick J.B, & Rahbar M.H. (2016). Multicollinearity in Regression Analyses Conducted in Epidemiologic Studies. Epidemiology (Sunnyvale, Calif.), 6(2), 227.
Publication 2016
Blood Pressure Eligibility Determination High Blood Pressures Hispanics Homo sapiens Index, Body Mass Obesity Obesity, Visceral Pressure Pressure, Diastolic Sound Sphygmomanometers Systolic Pressure Umbilicus Waist Circumference
3
Maternal Factors and Pregnancy Outcomes
We obtained information on maternal age, ethnicity, educational level, parity, folic acid supplementation, and smoking by questionnaire at enrolment.11 (link) Maternal height and weight were measured and body mass index was calculated at enrolment. We measured maternal blood pressure with the validated oscillometric sphygmomanometer (OMRON Healthcare Europe B V, Hoofddorp, Netherlands) and documented the mean value of two blood pressure readings.23 (link)
Jaddoe V.W., de Jonge L.L., Hofman A., Franco O.H., Steegers E.A, & Gaillard R. (2014). First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. The BMJ, 348, g14.
Publication 2014
Blood Pressure Ethnicity Folic Acid Index, Body Mass Oscillometry Sphygmomanometers
4
Cardiovascular Health Metric Assessment in ARIC

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2011
Antihypertensive Agents Cardiovascular System Cerebrovascular Accident Cholesterol Congestive Heart Failure Diagnosis Diet Electrocardiography, 12-Lead Enzymes Eyeglasses Fishes Food Fruit Glucose Glucosephosphate Dehydrogenase Heart Hexokinase Index, Body Mass Myocardial Infarction Pharmaceutical Preparations Physicians Plasma Serum Sodium Sphygmomanometers Sugar-Sweetened Beverages Vegetables Whole Grains Woman
5
ACCORD BP Trial: Intensive Hypertension Management
The ACCORD BP trial was a nonblinded trial in which participants were randomly assigned to intensive therapy that targeted systolic blood pressures of less than 120 mm Hg or standard therapy that targeted systolic blood pressures of less than 140 mm Hg. Treatment strategies that are currently available in clinical practice were used to lower blood pressure. Randomization was performed centrally on the study’s Web site with the use of permuted blocks to maintain concealment of future study-group assignments.
The approach to the management of blood pressure has been described elsewhere.4 The schedules of visits for the assessment and management of blood pressure differed according to treatment group. For participants in the intensive-therapy group, visits to assess blood pressure were scheduled once a month for 4 months and every 2 months thereafter; for participants in the standard-therapy group, visits were scheduled at months 1 and 4 and every 4 months thereafter. Additional visits were scheduled as needed in both groups to monitor and ensure appropriate implementation of the study intervention strategies. In both blood-pressure groups, participants who were assigned to intensive glycemic therapy had more frequent contacts for the management of glycemia, but blood pressure was not monitored at these additional visits.
The ACCORD BP trial was a study of a treatment strategy to achieve specific systolic blood-pressure goals, rather than an evaluation of any specific drug regimen. However, all the antihypertensive regimens were to include drug classes that had been shown to result in a reduction in cardiovascular events among participants with diabetes. Details of the assessment of blood pressure, the adjustment of medication doses, and antihypertensive drug regimens are provided in Sections 8 and 9 in Supplementary Appendix 1. Antihypertensive drugs were donated by Abbott Laboratories, AstraZeneca Pharmaceuticals, Glaxo-SmithKline Pharmaceuticals, King Pharmaceuticals, Sanofi-Aventis U.S., and Novartis Pharmaceuticals. Sphygmomanometers were donated by Omron Healthcare. The companies that donated the drugs and devices had no role in the design of the study, the accrual or analysis of the data, or the preparation of the manuscript.
At the 4-month visits that both treatment groups were scheduled to attend, information on study outcomes and adverse events was ascertained, blood samples were obtained, and clinical examinations were performed. The occurrence of self-reported symptoms of swelling or of dizziness on standing during the previous month was assessed as part of a standardized symptom checklist that was administered at baseline and at 1, 3, and 4 years after randomization to a random sample of 969 participants who were assessed for health-related quality of life.
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. (2010). The New England journal of medicine, 362(17), 1575-1585.
Publication 2010
Antihypertensive Agents BLOOD Blood Pressure Cardiovascular System Diabetes Mellitus Group Therapy Medical Devices Pharmaceutical Preparations Physical Examination Pressure Sphygmomanometers Systolic Pressure Treatment Protocols

Most recents protocols related to «Sphygmomanometers»

1
Comprehensive Health Evaluation of Postmenopausal Women
A structured and detailed survey designed by professional physicians was used to collect the demographic and clinical parameters of the study subjects including self-reported illness and the currently used medications. The number of subjects in the smoking and alcohol consumption groups were low among early postmenopausal women, and were therefore excluded from analysis. Systolic and diastolic blood pressure was measured using an electronic brachial sphygmomanometer (T30J, OMRON, Japan). Anthropometric parameters including height, weight, waist circumference, and hip circumference were measured using standard procedures by well-trained nurses. Blood samples (8–10 mL) were collected from the antecubital vein after at least 8 h of overnight fasting and evaluated in the laboratory center within 24 h. Metabolic biomarkers and liver function parameters including fasting blood glucose (FBG), triglycerides (TGs), total cholesterol (TC), low-density-lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), serum uric acid (UA), serum aspartate aminotransferase (AST), and serum alanine aminotransferase (ALT) levels were measured. Furthermore, the blood counts of white blood cells (WBC) and neutrophils (NE) were also analyzed. Abdominal ultrasonography was performed using the SIEMENS ACUSON S2000 ABVS ultrasound scanner (Siemens Healthineers, Erlangen, Germany), and was operated by experienced ultra-sonographers. The data was recorded in the electronic medical system of the Health Examination Center.
Lu Y., Ge L., Yang H., He Y, & Wang Y. (2023). Chinese Visceral Adipose Index Shows Superior Diagnostic Performance in Predicting the Risk of Metabolic Dysfunction Associated Fatty Liver Disease in Early Postmenopausal Chinese Women. Diabetes, Metabolic Syndrome and Obesity, 16, 607-617.
Publication 2023
Abdomen Alanine Transaminase Aspartate Transaminase Biological Markers BLOOD Blood Glucose Cholesterol Cholesterol, beta-Lipoprotein High Density Lipoprotein Cholesterol Leukocytes Liver Neutrophil Nurses Pharmaceutical Preparations Physicians Pressure, Diastolic Serum Sphygmomanometers Systole Triglycerides Ultrasonography Uric Acid Veins Waist Circumference Woman
2
Blood Pressure and Glycemic Control Measurement
Blood pressure was measured on the left arm in sitting posture during the visit by the physician using an aneroid sphygmomanometer with a stethoscope.
Glycemic control was explained by HbA1c (the gold standard measurement of glycemic control) [10 (link)]. The last three-month HbA1c value was extracted from the medical records of patients with diabetes, or was measured from a vein during the routine visit.
Kálcza Jánosi K, & Lukács A. (2023). Independent and interactive effect of type 2 diabetes and hypertension on memory functions in middle aged adults. BMC Endocrine Disorders, 23, 59.
Full text: Click here
Publication 2023
Blood Pressure Diabetes Mellitus Glycemic Control Gold Patients Physicians Sphygmomanometers Stethoscopes Veins
3
Comprehensive Assessment of Lifestyle, Health, and Anthropometric Factors
Using a self-constructed face-to-face interview questionnaire, data were collected with multistage stratified random sampling. The data included detailed demographic and socioeconomic information (sex, marital status, educational levels, workplace, experience, monthly income, etc.), lifestyle involved (sleep duration, workload, work routine, and physical activity [measured by the International Physical Activity Questionnaire, IPAQ-short version]) (23 (link)); the health profile involved [dietary patterns adapted from questions used in the food frequency questionnaire (24 (link), 25 (link))], menstrual cycle, family history of the disease, medical records, etc. After analyzing the literature on the subject, the questionnaire was well-prepared. The questionnaire's validity was tested by sending the completed questionnaire and a cover letter explaining the study's goal to 10 experts in various health professions (associated professors, hospital directors, managers of health departments, and academic teachers) who were asked to comment on the questionnaire. From the original English edition, all questions were translated into Arabic (forward and English and Arabic mother-tongue speakers performed backward translations). The study's research team consisted of five workers, physicians, and nurses, who collected the questionnaires by filling out the printed sheets.
Expert nurses measured each participant's anthropometric data by using standard protocols (26 (link), 27 ), and height and weight were measured using stadiometers and weighing scales, respectively (26 (link)). A measuring tape was positioned 1 cm below the umbilicus and at the iliac crest to measure the circumferences of the waist and hips, respectively (27 ). The body mass index (BMI) formula (kg/m2) = Weight (kg)/Height squared (m2) (28 (link)) was used to calculate the BMI. We defined obesity according to WHO criteria; where underweight people had a BMI of <18.5 kg/m2, normal weight had a BMI of 18.5–24.9 kg/m2, overweight had a BMI of 25.0–29.9 kg/m2, and obese were over 30.0 kg/m2 (29 (link)).
The blood pressure (BP) values were taken with a sphygmomanometer. After participants had rested in a sitting position for at least 10 min, experienced nurses took two measurements on the right arm at a properly sized cuffed 1-min interval, with the arm supported at heart level and feet flat on the floor (30 (link)).
Younis J., Jiang H., Fan Y., Wang L., Li Z., Jebril M., Ma M., Ma L., Ma M, & Hui Z. (2023). Prevalence of overweight, obesity, and associated factors among healthcare workers in the Gaza Strip, Palestine: A cross-sectional study. Frontiers in Public Health, 11, 1129797.
Full text: Click here
Publication 2023
Blood Pressure Coxa Diet Face Food Foot Heart Iliac Crest Index, Body Mass Menstrual Cycle Mothers Nurses Obesity Physicians Sphygmomanometers Tongue Umbilicus Waist Circumference Workers
4
Angiotensin II-Induced Gene Expression
The effects of αv knockout on gene expression were examined at 6 weeks after tamoxifen injection followed or not by a 4-week treatment with Ang II. Anaesthesia was induced by isoflurane inhalation at 3.5% in 1 L/min oxygen, and then maintained at 1.5% in 1 L/min oxygen during the intervention. Angiotensin II was administered at 1.5 mg/kg/day for 28 days via subcutaneous Alzet osmotic minipumps (Charles River, L’Arbresle, France). Prior to pump implantation, mice were conditioned to tail-cuff blood pressure measurement using a computerized mouse tail-cuff sphygmomanometer (Hatteras Instruments, Inc., NC, USA). Systolic arterial pressure (SAP) and heart rate (HR) were measured on the day of surgery and on day 28 prior to euthanasia. Mice were euthanized via exsanguination under isoflurane anaesthesia (1.5% in 1 L/min oxygen). Carotid arteries were used for morphological and histological analyses and thoracic aorta for all other parameters. It is generally accepted including our previous studies that changes in gene and/or protein expression are similar in these two main conductance arteries.14 (link),15 (link)
Li Z., Belozertseva E., Parlakian A., Bascetin R., Louis H., Kawamura Y., Blanc J., Gao-Li J., Pinet F., Lacy-Hulbert A., Challande P., Humphrey J.D., Regnault V, & Lacolley P. (2023). Smooth muscle αv integrins regulate vascular fibrosis via CD109 downregulation of TGF-β signalling. European Heart Journal Open, 3(2), oead010.
Publication 2023
Anesthesia Angiotensin II Arteries Carotid Arteries Determination, Blood Pressure Euthanasia Exsanguination Gene Expression Genes Inhalation Isoflurane Mus Osmosis Ovum Implantation Oxygen Proteins Rate, Heart Rivers Sphygmomanometers Surgery, Day Systolic Pressure Tail Tamoxifen Thoracic Aorta
5
Comprehensive Health Assessments in Community-Based Settings
Biometric assessments were performed at baseline, 12 weeks, and 24 weeks. Data from participants included self-reported measures (sociodemographic and self-reported health history), survey data collected via REDCap, including the CMS Accountable Health Communities Health-Related Social Needs Screening Tool either onsite at the Recreation and Parks locations or at participant homes [30 (link)]. Biometric measurements, including blood pressure (mmHg), fasting cholesterol (mg/dl), fasting glucose (mg/dl), weight (lbs), and BMI were collected onsite at the Recreation and Parks locations and recorded in REDCap at each time point. The sociodemographic data included age, education, race, ethnicity, employment status, insurance status, and annual income. The self-reported health history included hypertension, diabetes, hyperlipidemia, and smoking status (I have never smoked, I currently smoke, I quit smoking > 1 year ago or I quit smoking ≤ 1 year ago), as well as medications for the aforementioned chronic conditions.
The survey data included the Diet History Questionnaire (DHQ) III [40 ]. The DHQ-III nutrient and food group database is based on a compilation of national 24-hour dietary recall data from the National Health and Nutrition Examination Surveys (NHANES). Prior research has shown the questionnaire is valid and reliable [41 (link)–43 (link)]. In the current evaluation, we calculated physical activity minutes per week using the validated moderate physical activity 2-question physical activity questionnaire within the CMS screening tool [44 (link)].
Biometric screenings were performed by trained healthcare staff, including nurses and physicians. Blood pressure was checked via an automated oscillometric sphygmomanometer (Omron 5 series) with two measurements performed after the participants were seated for 5 minutes and averaged. Weight was measured using a zeroed and calibrated Omron Body Composition Monitor and Scale (Model: HBF-514C). Height was measured via a tape measurer. BMI was calculated by multiplying weight (lbs) by 703 and then dividing by height squared (inch2). Blood total cholesterol and glucose were measured in the fasting state using the Cardio Check Silver® (Polymer Technology, Inc., Heath, OH, USA) device. All participants received individual results at baseline, 12, and 24 weeks.
Joseph J.J., Gray DM I.I., Williams A., Zhao S., McKoy A., Odei J.B., Brock G., Lavender D., Walker D.M., Nawaz S., Baker C., Hoseus J., Price T., Gregory J, & Nolan T.S. (2023). Addressing non-medical health-related social needs through a community-based lifestyle intervention during the COVID-19 pandemic: The Black Impact program. PLOS ONE, 18(3), e0282103.
Full text: Click here
Publication 2023
BLOOD Blood Pressure Body Composition Cholesterol Chronic Condition Diabetes Mellitus Diet Ethnicity Food Glucose High Blood Pressures Hyperlipidemia Medical Devices Mental Recall Nurses Nutrients Oscillometry Pharmaceutical Preparations Physicians Polymers Screening Silver Smoke Sphygmomanometers

Top products related to «Sphygmomanometers»

1
Hem 907 by Omron
Sourced in Japan, United Kingdom, United States, Greece, Australia
The HEM-907 is a digital blood pressure monitor device designed for professional use in a medical or clinical setting. The device measures and displays systolic and diastolic blood pressure, as well as pulse rate. It is intended for use by healthcare professionals to assist in the diagnosis and management of hypertension.
2
Hem 907xl by Omron
Sourced in Japan, United States, United Kingdom
The HEM-907XL is an automated blood pressure monitor designed for professional use in clinical settings. It is capable of measuring systolic and diastolic blood pressure, as well as pulse rate. The device features a large, easy-to-read display and is powered by AC adapter.
3
Bp 98a by Softron
Sourced in Japan, China
The BP-98A is a laboratory instrument designed for measuring blood pressure. It provides accurate readings of systolic and diastolic blood pressure values.
4
Electronic sphygmomanometer by Omron
Sourced in Japan, China
The Omron Electronic Sphygmomanometer is a medical device used for measuring blood pressure. It utilizes electronic sensors to detect and record systolic and diastolic blood pressure readings.
5
Automatic analyzer 7600 by Hitachi
Sourced in Japan, United States, Germany, Finland
The Hitachi Automatic Analyzer 7600 is a versatile laboratory instrument designed for the automated analysis of various samples. It is capable of performing a wide range of clinical chemistry tests, including quantitative determination of analytes in biological fluids.
6
Hbp 1300 by Omron
Sourced in Japan, China, United States
The HBP-1300 is a compact, digital blood pressure monitor designed for professional use. It features an easy-to-read display and can be operated with one hand. The device is intended for measuring blood pressure and pulse rate.
7
Stadiometer by Seca
Sourced in Germany, United Kingdom, United States, Japan, Jamaica, Switzerland, Brazil
A stadiometer is a medical device used to measure a person's height. It consists of a vertical scale, typically marked in centimeters or inches, with a horizontal headpiece that can be lowered to rest on top of the person's head, allowing for an accurate measurement of their stature.
8
Hem 7200 by Omron
Sourced in Japan, China, United States
The HEM-7200 is an automated blood pressure monitor designed for professional use in medical settings. It features a digital display and automatic inflation and deflation of the cuff to measure the user's systolic and diastolic blood pressure, as well as heart rate. The device is intended for use by healthcare professionals for the purpose of obtaining accurate blood pressure readings.
9
Sphygmomanometer by Omron
Sourced in Japan, United Kingdom
The Sphygmomanometer is a medical device used to measure a person's blood pressure. It consists of an inflatable cuff that is wrapped around the upper arm, and a mechanism to measure the pressure within the cuff as it is inflated and deflated. The Sphygmomanometer allows healthcare professionals to accurately record a person's systolic and diastolic blood pressure readings.
10
Hbp 9020 by Omron
Sourced in Japan, China
The HBP-9020 is a compact and portable blood pressure monitor designed for professional use. It features automatic inflation and deflation for precise measurement, and can store up to 90 readings. The HBP-9020 is intended for use in clinical settings by healthcare professionals.

More about "Sphygmomanometers"

Sphygmomanometers, also known as blood pressure monitors or manometers, are essential medical devices used to measure an individual's blood pressure.
These instruments typically consist of an inflatable cuff that wraps around the arm and a pressure-measuring device, often with a digital display or analog gauge.
Sphygmomanometers play a crucial role in the diagnosis and management of hypertension, a major risk factor for cardiovascular disease.
Researchers and healthcare professionals utilize sphygmomanometers to obtain accurate, reproducible, and reliable blood pressure readings, which are vital for patient care and clinical decision-making.
Ongoing research in this field focuses on improving the accuracy, precision, and reliability of these devices, as well as exploring related technologies like the HEM-907, HEM-907XL, BP-98A, and Electronic sphygmomanometers.
To optimize their sphygmomanometer research protocols, researchers may leverage AI-powered tools like PubCompare.ai.
This platform helps streamline the research process by providing data-driven insights, facilitating access to the latest literature, and enabling comparisons of protocols from various sources, including pre-prints and patents.
By using PubCompare.ai, researchers can enhance the quality and effectiveness of their sphygmomanometer-related investigations, ultimately contributing to improved patient care and outcomes.
Furthermore, sphygmomanometer research may intersect with other medical technologies, such as the Hitachi Automatic Analyzer 7600, HBP-1300, Stadiometer, and HEM-7200.
Understanding the synergies and interactions between these devices can lead to more comprehensive and integrated approaches to healthcare.
In summary, sphygmomanometers are indispensable tools in the medical field, and ongoing research in this area is crucial for advancing our understanding and improving patient care.
By utilizing AI-powered platforms like PubCompare.ai and exploring related technologies, researchers can streamline their work, access the latest insights, and deliver more reliable and impactful results for sphygmomanometer-related studies.